Skip to main content
Erschienen in: Journal of Neurology 10/2020

10.06.2020 | Original Communication

Dyspnea after subthalamic deep brain stimulation in Parkinson’s disease: a case–control study

verfasst von: Sara Meoni, Ana C. Bradi, Pettarusp Wadia, Yu-Yan Poon, Elena Moro

Erschienen in: Journal of Neurology | Ausgabe 10/2020

Einloggen, um Zugang zu erhalten

Abstract

Objective

Dyspnea can be present as non-motor symptom in patients with Parkinson’s disease (PD). Deep brain stimulation (DBS) of the subthalamic nucleus (STN) improves motor and non-motor symptoms in PD. However, new-onset dyspnea has been reported after DBS surgery. We have studied respiratory characteristics of PD patients with bilateral STN-DBS to assess the impact of DBS on pulmonary function.

Methods

STN-DBS PD patients with dyspnea after surgery (cases) were matched with STN-DBS PD patients without dyspnea (controls). Motor and pulmonary function were assessed with stimulation and without medication (on stim/off med), and without stimulation and medication (off stim/off med). Pulmonary function was investigated with spirometry and dyspnea with the Medical Research Council Dyspnea Scale (MRCDS) and the Borg Scale (BS).

Results

Seven cases (five men, 58.30 ± 6.70 years of age) and seven controls (six men, 61.10 ± 6.30 years of age) were enrolled. MRCDS and BS revealed the presence of dyspnea in both groups. No significant changes in pulmonary function were found in both cases and controls in on stim/off med vs. off stim/off med condition (p < 0.05), and in cases vs. controls in on stim/ off med condition (p < 0.05).

Conclusions

No impact of STN-DBS on pulmonary function was found in cases. Impaired perception of dyspnea and spread of stimulation surrounding the STN might account for new-onset dyspnea after DBS surgery. Dyspnea was detected also in controls using ad hoc questionnaires. Our findings suggest further investigation of this non-motor symptom in PD patients.
Literatur
1.
Zurück zum Zitat Susan HF, Lang AE (2007) Motor and nonmotor fluctuations. In: Handbook of clinical neurology. Elsevier, Edinburgh, pp 159–184 Susan HF, Lang AE (2007) Motor and nonmotor fluctuations. In: Handbook of clinical neurology. Elsevier, Edinburgh, pp 159–184
2.
Zurück zum Zitat Parshall MB, Schwartzstein RM, Adams L, Banzett RB, Manning HL, Bourbeau J et al; American Thoracic Society Committee on Dyspnea (2012) An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med 4:435–452 Parshall MB, Schwartzstein RM, Adams L, Banzett RB, Manning HL, Bourbeau J et al; American Thoracic Society Committee on Dyspnea (2012) An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med 4:435–452
3.
Zurück zum Zitat Barone P, Antonini A, Colosimo C, Marconi R, Morgante L, Avarello TP et al (2009) The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov Disord 1641–1649 Barone P, Antonini A, Colosimo C, Marconi R, Morgante L, Avarello TP et al (2009) The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov Disord 1641–1649
4.
Zurück zum Zitat Baille G, Chenivesse C, Perez T, Machuron F, Dujardin K, Devos D et al (2019) Dyspnea: an underestimated symptom in Parkinson's disease. Parkinsonism Relat Disord 60:162–166CrossRef Baille G, Chenivesse C, Perez T, Machuron F, Dujardin K, Devos D et al (2019) Dyspnea: an underestimated symptom in Parkinson's disease. Parkinsonism Relat Disord 60:162–166CrossRef
5.
Zurück zum Zitat Baille G, Perez T, Devos D, Machuron F, Dujardin K, Chenivesse C et al (2019) Dyspnea is a specific symptom in Parkinson's disease. J Parkinson’s Dis 9(4):785–791CrossRef Baille G, Perez T, Devos D, Machuron F, Dujardin K, Chenivesse C et al (2019) Dyspnea is a specific symptom in Parkinson's disease. J Parkinson’s Dis 9(4):785–791CrossRef
6.
Zurück zum Zitat Onodera H, Okabe S, Kikuchi Y, Tsuda T, Itoyama Y (2000) Impaired chemosensitivity and perception of dyspnea in Parkinson’s disease. Lancet 9231:739–740CrossRef Onodera H, Okabe S, Kikuchi Y, Tsuda T, Itoyama Y (2000) Impaired chemosensitivity and perception of dyspnea in Parkinson’s disease. Lancet 9231:739–740CrossRef
7.
Zurück zum Zitat Storch A, Schneider CB, Wolz M, Sturwald Y, Nebe A, Odin P et al (2013) Nonmotor fluctuations in Parkinson disease: severity and correlation with motor complications. Neurology 9:800–809CrossRef Storch A, Schneider CB, Wolz M, Sturwald Y, Nebe A, Odin P et al (2013) Nonmotor fluctuations in Parkinson disease: severity and correlation with motor complications. Neurology 9:800–809CrossRef
8.
Zurück zum Zitat De Pandis MF, Starace A, Stefanelli F, Marruzzo P, Meoli I, De Simone G et al (2002) Modification of respiratory function parameters in patients with severe Parkinson’s disease. Neurol Sci Suppl 2:69–70CrossRef De Pandis MF, Starace A, Stefanelli F, Marruzzo P, Meoli I, De Simone G et al (2002) Modification of respiratory function parameters in patients with severe Parkinson’s disease. Neurol Sci Suppl 2:69–70CrossRef
9.
Zurück zum Zitat Herer B, Arnulf I (2001) Housset B Effects of levodopa on pulmonary function in Parkinson’s disease. Chest 2:387–393CrossRef Herer B, Arnulf I (2001) Housset B Effects of levodopa on pulmonary function in Parkinson’s disease. Chest 2:387–393CrossRef
10.
Zurück zum Zitat Guedes LU, Rodrigues JM, Fernandes AA, Cardoso FE, Parreira VF (2012) Respiratory changes in Parkinson’s disease may be unrelated to dopaminergic dysfunction. Arq Neuropsiquiatr 11:847–851CrossRef Guedes LU, Rodrigues JM, Fernandes AA, Cardoso FE, Parreira VF (2012) Respiratory changes in Parkinson’s disease may be unrelated to dopaminergic dysfunction. Arq Neuropsiquiatr 11:847–851CrossRef
12.
Zurück zum Zitat Pal PK, Sathyaprabha TN, Tuhina P et al (2007) Pattern of subclinical pulmonary dysfunctions in Parkinson's disease and the effect of levodopa. Mov Disord 22(3):420–424CrossRef Pal PK, Sathyaprabha TN, Tuhina P et al (2007) Pattern of subclinical pulmonary dysfunctions in Parkinson's disease and the effect of levodopa. Mov Disord 22(3):420–424CrossRef
13.
Zurück zum Zitat Rice JE, Antic R, Thompson PD (2002) Disordered respiration as a levodopa-induced dyskinesia in Parkinson’s disease. Mov Disord 3:524–527CrossRef Rice JE, Antic R, Thompson PD (2002) Disordered respiration as a levodopa-induced dyskinesia in Parkinson’s disease. Mov Disord 3:524–527CrossRef
14.
Zurück zum Zitat Dafsari HS, Silverdale M, Strack M, Rizos A, Ashkan K, Mahlstedt P et al (2018) EUROPAR and the IPMDS Non Motor PD Study Group. Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson's disease. Mov Disord 33(3):421–430 Dafsari HS, Silverdale M, Strack M, Rizos A, Ashkan K, Mahlstedt P et al (2018) EUROPAR and the IPMDS Non Motor PD Study Group. Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson's disease. Mov Disord 33(3):421–430
15.
Zurück zum Zitat Jiang L, Poon WS, Moro E, Xian W, Yang C, Zhu XL et al (2017) Early versus late application of subthalamic deep brain stimulation to Parkinson's disease patients with motor complications (ELASS): protocol of a multicentre, prospective and observational study. BMJ Open 16 7(11):e018610 Jiang L, Poon WS, Moro E, Xian W, Yang C, Zhu XL et al (2017) Early versus late application of subthalamic deep brain stimulation to Parkinson's disease patients with motor complications (ELASS): protocol of a multicentre, prospective and observational study. BMJ Open 16 7(11):e018610
16.
Zurück zum Zitat Hyam JA, Brittain JS, Paterson DJ, Davies RJ, Aziz TZ, Green AL (2012) Controlling the lungs via the brain: a novel neurosurgical method to improve lung function in humans. Neurosurgery 70(2):469–478CrossRef Hyam JA, Brittain JS, Paterson DJ, Davies RJ, Aziz TZ, Green AL (2012) Controlling the lungs via the brain: a novel neurosurgical method to improve lung function in humans. Neurosurgery 70(2):469–478CrossRef
17.
Zurück zum Zitat Chalif JI, Sitsapesan HA, Pattinson KT, Herigstad M, Aziz TZ, Green AL (2014) Dyspnea as a side effect of subthalamic nucleus deep brain stimulation for Parkinson's disease. Respir Physiol Neurobiol 192:128–133CrossRef Chalif JI, Sitsapesan HA, Pattinson KT, Herigstad M, Aziz TZ, Green AL (2014) Dyspnea as a side effect of subthalamic nucleus deep brain stimulation for Parkinson's disease. Respir Physiol Neurobiol 192:128–133CrossRef
18.
Zurück zum Zitat Kawaguchi M, Samura K, Miyagi Y, Okamoto T, Yamasaki R, Sakae N et al (2020) The effects of chronic subthalamic stimulation on nonmotor symptoms in advanced Parkinson's disease, revealed by an online questionnaire program. Acta Neurochir (Wien) 162(2):247–255CrossRef Kawaguchi M, Samura K, Miyagi Y, Okamoto T, Yamasaki R, Sakae N et al (2020) The effects of chronic subthalamic stimulation on nonmotor symptoms in advanced Parkinson's disease, revealed by an online questionnaire program. Acta Neurochir (Wien) 162(2):247–255CrossRef
19.
Zurück zum Zitat Kumar R, Lozano AM, Kim YJ et al (1998) Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease. Neurology 51(3):850–855CrossRef Kumar R, Lozano AM, Kim YJ et al (1998) Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease. Neurology 51(3):850–855CrossRef
20.
Zurück zum Zitat Fahn S, Elton RL, Committee motUd (1987) Unified Parkinson’s disease rating scale. In: Fahn S, Marsden CD, Calne DB (eds) Recent developments in Parkinson’s disease. MacMillan Health Care Information, Florham Park, pp 153–164 Fahn S, Elton RL, Committee motUd (1987) Unified Parkinson’s disease rating scale. In: Fahn S, Marsden CD, Calne DB (eds) Recent developments in Parkinson’s disease. MacMillan Health Care Information, Florham Park, pp 153–164
21.
Zurück zum Zitat Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA (1999) Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 54:581–586CrossRef Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA (1999) Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 54:581–586CrossRef
22.
Zurück zum Zitat Borg GA (1982) Psychophysical bases of perceived exertion. Med Sci Sports Exerc 14:377–381 Borg GA (1982) Psychophysical bases of perceived exertion. Med Sci Sports Exerc 14:377–381
23.
Zurück zum Zitat Papathanasiou JV, Ilieva E, Marinov B (2013) Six-minute walk test: an effective and necessary tool in modern cardiac rehabilitation. Hellenic J Cardiol 54:126–130PubMed Papathanasiou JV, Ilieva E, Marinov B (2013) Six-minute walk test: an effective and necessary tool in modern cardiac rehabilitation. Hellenic J Cardiol 54:126–130PubMed
24.
Zurück zum Zitat Chapman KR, Cox G, Davis L, Gottschalk R, Ho B, Nedar A, et al. (2014) Independent health facilities, clinical practice parameters and facility standards, pulmonary function facilities, 4th edn. College of Physicians and Surgeons of Ontario, Toronto Chapman KR, Cox G, Davis L, Gottschalk R, Ho B, Nedar A, et al. (2014) Independent health facilities, clinical practice parameters and facility standards, pulmonary function facilities, 4th edn. College of Physicians and Surgeons of Ontario, Toronto
25.
Zurück zum Zitat Yanase M, Kataoka H, Kawahara M et al (2008) Fixed epiglottis associated with subthalamic nucleus stimulation in Parkinson's disease. J Neurol Neurosurg Psychiatry 79(3):332–333CrossRef Yanase M, Kataoka H, Kawahara M et al (2008) Fixed epiglottis associated with subthalamic nucleus stimulation in Parkinson's disease. J Neurol Neurosurg Psychiatry 79(3):332–333CrossRef
26.
Zurück zum Zitat Weiner P, Inzelberg R, Davidovich A, Nisipeanu P, Magadle R, Berar-Yanay N, Carasso RL (2002) Respiratory muscle performance and the Perception of dyspnea in Parkinson’s disease. Can J Neurol Sci 29:68–72CrossRef Weiner P, Inzelberg R, Davidovich A, Nisipeanu P, Magadle R, Berar-Yanay N, Carasso RL (2002) Respiratory muscle performance and the Perception of dyspnea in Parkinson’s disease. Can J Neurol Sci 29:68–72CrossRef
27.
Zurück zum Zitat Komiya H, Kimura K, Kishida H, Kawasaki T, Hamada K, Koizumi H, Ueda N, Tanaka F (2019) Adjustment of subthalamic deep brain stimulation parameters improves wheeze and dyspnea in Parkinson's disease. Front Neurol 13:10–1317 Komiya H, Kimura K, Kishida H, Kawasaki T, Hamada K, Koizumi H, Ueda N, Tanaka F (2019) Adjustment of subthalamic deep brain stimulation parameters improves wheeze and dyspnea in Parkinson's disease. Front Neurol 13:10–1317
28.
Zurück zum Zitat Temperli P, Ghika J, Villemure JG, Burkhard PR, Bogousslavsky J, Vingerhoets FJ (2003) How do parkinsonian signs return after discontinuation of subthalamic DBS? Neurology 60:78–81CrossRef Temperli P, Ghika J, Villemure JG, Burkhard PR, Bogousslavsky J, Vingerhoets FJ (2003) How do parkinsonian signs return after discontinuation of subthalamic DBS? Neurology 60:78–81CrossRef
Metadaten
Titel
Dyspnea after subthalamic deep brain stimulation in Parkinson’s disease: a case–control study
verfasst von
Sara Meoni
Ana C. Bradi
Pettarusp Wadia
Yu-Yan Poon
Elena Moro
Publikationsdatum
10.06.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 10/2020
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-020-09976-0

Weitere Artikel der Ausgabe 10/2020

Journal of Neurology 10/2020 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.